DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-6.74%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.47B
AUM Growth
+$4.47B
(-5.9%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
41.88%
Holding
141
New
13
Increased
10
Reduced
16
Closed
18
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$48.9M |
| 2 |
Gilead Sciences
GILD
|
$45.5M |
| 3 |
Pulmonx
LUNG
|
$33M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$26.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
$26.2M |
Top Sells
| 1 |
APR
Apria, Inc. Common Stock
APR
|
$54M |
| 2 |
Glaukos
GKOS
|
$45.8M |
| 3 |
Protagonist Therapeutics
PTGX
|
$40.1M |
| 4 |
Centene
CNC
|
$37.9M |
| 5 |
Pacira BioSciences
PCRX
|
$35.9M |
Sector Composition
| 1 | Healthcare | 54.47% |
| 2 | Financials | 1.5% |
| 3 | Consumer Discretionary | 0% |
